Effects of some antibiotics on paraoxonase from human serum in vitro and from mouse serum and liver in vivo

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 8, 2006, Pages 1559-1563

  Sinan, Selma ^a   Kockar, Feray ^a   Gencer, Nahit ^a   Yildirim, Hatice ^a   Arslan, Oktay ^a  

^a BALIKESIR UNIVERSITY   (Turkey)

Author keywords

Antibiotics; IC50; In vitro; In vivo; Inhibition; Paraoxonase

Indexed keywords

AMMONIUM SULFATE; AMPICILLIN; ANTIBIOTIC AGENT; ARYLDIALKYLPHOSPHATASE; CIPROFLOXACIN; CLINDAMYCIN PHOSPHATE; DEXAMETHASONE; FLUINDOSTATIN; HYDROLYASE; PARAOXON; PRAVASTATIN; RIFAMYCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHROMATOGRAPHY; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME PURIFICATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; LIVER; MOUSE; NONHUMAN; PRECIPITATION; SERUM;

ANIMALS; ANTI-BACTERIAL AGENTS; ARYLDIALKYLPHOSPHATASE; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME INHIBITORS; HUMANS; LIVER; MICE;

EID: 33746773687     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.1559     Document Type: Article

References (35)

1. Mackness M. I., Mackness B., Durrington P. N., Conelly P. W., Hegele R. A., Curr. Opin. Lipidol., 7, 69-76 (1996).
2. Aldridge W. N., Biochem. J., 53, 117-124 (1953).
3. La Du B. N., "Pharmogenetics of Drug Metabolism," ed. by Kalow W., Pergamon Press, New York, 1992, pp. 51-91.
4. Sogorb M. A., Vilanova E., Toxicol. Lett., 128, 215-228 (2002).
5. Biggadike K., Angell R. M., Burgess C. M., Farrell R. M., Hancock A. P., Harker A. J., Irving W. R., Ioannou C., Panayiotis A., Procopiou P. A., Shaw R. E., Solanke Y. E., Singh O. M. P., Snowden M. A., Stubbs R. J., Walton S., Weston H. E., J. Med. Chem., 43, 19-21 (2000).
6. Durringhton P. N., Mackness B., Mackness M. I., Arterioscler. Thromb. Vasc. Biol., 21, 473-482 (2001).
7. Jakubowski H., J. Biol. Chem., 275, 3957-3962 (2000).
8. Draganov D. I., La Du B. N., Naunyn Schmiedebergs Arch. Pharmacol., 369, 78-88 (2004).
9. Reddy S. T., Wadleigh D. J., Grijalva V., Ng C., Hama S., Gangopadhyay A., Shih D. M., Lusis A. J., Navab M., Fogelman A. M., Arterioscler. Thromb. Vasc. Biol., 21, 542-547 (2001).
10. Ng C. J., Wadleigh D. J., Gangopadhyay A., J. Biol. Chem., 276, 44444-44449 (2001).
11. Malin R., Knuuti J., Janatuinen T., Laaksonen R., Vesalainen R., Nuutila P., Jokela H., Laakso J., Jaakkola O., Solakivi T., Lehtimaki T., J. Mol. Med., 79, 449-458 (2001).
12. Tomas M., Senti M., Garcia-Faria F., Vila J., Torrents A., Covas M., Marrugat J., Arterioscler. Thromb. Vasc. Biol., 20, 2113-2119 (2000).
13. Leviev I., James R., Atherosclerosis, 151, 41-50 (2000).
14. Gan K. N., Smolen A., Eckerson H. W., La Du B. N., Drug Metab. Dispos., 19,100-106 (1991).
15. Bradford M. M., Anal. Biochem., 72, 248-251 (1976).
16. Sinan S., Arslan O., Kockar F., Gencer N., Bozkurt H. I., Int. Conf. "Paraoxonases Basic and Clinical Directions of Current Research," April, Michigan Union, University of Michigan, Ann Arbor, U.S.A., 2004, pp. 22-24.
17. Laemmli U. K., Nature (London), 227, 680-685 (1970).
18. Gil F., Pla A., Gonzalvo M. C., Hernández A. F., Villanueva E., Chem. Biol. Interact., 87, 69-75 (1993).
19. Tougou K., Nakamura A., Watanabe S., Okuyama Y., Morino A., Drug Metab. Dispos., 26, 355-359 (1998).
20. Rodrigo L., Gil F., Hernandez F. A., Lopez O., Pla A., Biochem. J. Imm. Pub. 15, 376, 261-268 (2003).
21. Furlong C. E., Costa L. G., Hasett C., Richter R. J., Sundstrom J. A., Adler D. A., Disteche C. M., Omiecinski C. J., Crabb J. W., Humbert R., Chem-Biol. İnteract., 87, 35-48 (1993).
22. Rodrigo L., Gil F., Hernandez A. F., Marina A., Vazquez J., Pla A., Biochem. J., 321, 595-601 (1997).
23. Reiner E., Aldridge W. N., Hoskin F. C. G., "Enzymes Hydrolyzing Organophosphorus Compounds," John Wiley & Sons, Inc., New York, 1989.
24. Beydemir Ş., Çiftçi M., Özmen İ., Okuroǧlu M. E. B., Özdemir H., Küfrevioǧlu Ö. İ., Pharmacol. Res., 42, 187-191 (2000).
25. Çiftçi M., Küfrevioǧlu Ö. İ., Gündoǧdu M., Özmen İ., Pharmacol. Res., 41, 109-113 (2000).
26. Perrone C., Takahashi K. C., Williams G. M., Toxicological Science, 69, 16-22 (2002).
27. Barret J. F., Gootz T. D., McGuirk P. R., Farrel C. A., Sokolowski S. A., Antimicrob. Agents Chemother., 33, 1697-1703 (1989).
28. Fuhr U., Anders E-M., Mahr G., Sorgel F., Staib A. H., Anrinzign,b AgcutN Chenithe, 36, 942-948 (1992).
29. Spisani S., Traniello S., Onori A. M., Rizzuti O., Martuccio C., Callai L., Inflammation, 22, 459-469 (1998).
30. Gouedard C., Koum-Besson N., Barouki R., Morel Y., Mol. Pharmacol., 63, 945-956 (2003).
31. Aviram M., Rosenblat M., Bisgaier C. L., Newton R. S., Atherosclerosis, 138, 271-280 (1998).
32. Beltowski J., Wojcicka G., Jamroz A., J. Cardiovasc. Pharmacol., 43, 121-127 (2004).
33. Ali B., Zhang Q., Lim Y. K., Feng D., Retnam L., Lim S. K., Free Radic. Biol. Med., 34, 824-833 (2003).
34. Sinan S., Kockar F., Gencer N., Yildirim H., Arslan O., Biochemistry (Moscow), 71, 46-50 (2006).
35. Sinan S., Kockar F., Arslan F., Biochimie, 88, 565-574 (2006).